We are live on ! Find out more
CIM

Contravisory Investment Management Portfolio holdings

AUM $566M
1-Year Est. Return 42.93%
This Fund
S&P 500
This Quarter Est. Return
+3.15%
1 Year Est. Return
+42.93%
3 Year Est. Return
+129.34%
5 Year Est. Return
+198.47%
10 Year Est. Return
+603.03%
AUM
$352M
AUM Growth
-$18.1M
Cap. Flow
-$17.4M
Cap. Flow %
-4.95%
Top 10 Hldgs %
26.46%
Holding
389
New
108
Increased
43
Reduced
115
Closed
59

Top Buys

Rank Stock Value
1
OKE icon
Oneok
OKE
+$6M
2
LLY icon
Eli Lilly
LLY
+$5.91M
3
ELV icon
Elevance Health
ELV
+$5.9M
4
ETR icon
Entergy
ETR
+$5.78M
5
EIX icon
Edison International
EIX
+$5.76M

Top Sells

Rank Stock Value
1
GRMN
Garmin
GRMN
+$8.98M
2
TREX icon
Trex
TREX
+$8.74M
3
TGT icon
Target
TGT
+$8.54M
4
JPM icon
JPMorgan Chase
JPM
+$5.65M
5
LEA icon
Lear
LEA
+$5.26M

Sector Composition

Rank Sector Weight
1 Financials 17.77%
2 Healthcare 14.81%
3 Energy 13.36%
4 Technology 12.51%
5 Real Estate 8.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GPI icon
201
Group 1 Automotive
GPI
$3.16B
$162K 0.05%
963
+27
+3% +$4.91K
WST icon
202
West Pharmaceutical
WST
$24.8B
$161K 0.05%
393
-181
-32% -$70.9K
AVT icon
203
Avnet
AVT
$7.99B
$160K 0.05%
3,932
XLC icon
204
State Street Communication Services Select Sector SPDR ETF
XLC
$22.6B
$155K 0.04%
2,258
-2,286
-50% -$161K
VSTO
205
DELISTED
Vista Outdoor Inc.
VSTO
$144K 0.04%
4,031
-809
-17% -$31.3K
BP icon
206
BP
BP
$110B
$138K 0.04%
4,705
VNQ icon
207
Vanguard Real Estate ETF
VNQ
$38.6B
$136K 0.04%
1,251
SCHM icon
208
Schwab US Mid-Cap ETF
SCHM
$15B
$132K 0.04%
5,202
+261
+5% +$6.54K
PBH icon
209
Prestige Consumer Healthcare
PBH
$2.51B
$129K 0.04%
+2,445
New +$141K
SBUX icon
210
Starbucks
SBUX
$119B
$126K 0.04%
1,390
XOM icon
211
ExxonMobil
XOM
$662B
$123K 0.03%
1,495
MDY icon
212
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$27B
$121K 0.03%
247
+3
+1% +$1.46K
SXT icon
213
Sensient Technologies
SXT
$5.51B
$121K 0.03%
+1,436
New +$121K
BMO icon
214
Bank of Montreal
BMO
$127B
$114K 0.03%
968
RY icon
215
Royal Bank of Canada
RY
$293B
$109K 0.03%
991
ING icon
216
ING
ING
$101B
$108K 0.03%
10,351
+1,328
+15% +$17.3K
OXY icon
217
Occidental Petroleum
OXY
$58.6B
$106K 0.03%
1,875
ABBV icon
218
AbbVie
ABBV
$438B
$105K 0.03%
650
ADI icon
219
Analog Devices
ADI
$187B
$105K 0.03%
636
-379
-37% -$61.4K
AEG icon
220
Aegon
AEG
$14B
$105K 0.03%
+20,657
New +$104K
DEO icon
221
Diageo
DEO
$54B
$104K 0.03%
514
GSK icon
222
GSK
GSK
$104B
$95K 0.03%
+1,748
New +$94.9K
AZO icon
223
AutoZone
AZO
$50.1B
$94K 0.03%
+46
New +$89.9K
SCHP icon
224
Schwab US TIPS ETF
SCHP
$16.2B
$93K 0.03%
3,070
-1,268
-29% -$38.9K
TSCO icon
225
Tractor Supply
TSCO
$18B
$91K 0.03%
+1,945
New +$86K

Similar funds

Contravisory Investment Management's Q1 2022 Portfolio in Review

As of Q1 2022, Contravisory Investment Management held 389 positions worth $352M, down 4.9% from $371M the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Contravisory Investment Management withdrew a net $17.4M in Q1 2022, closing 59 positions and reducing 115 holdings. Its most notable exit was Garmin, an estimated $8.98M position sold in full.

By sector, the portfolio is most concentrated in Financials at 18% of assets, down from 18% a quarter earlier, followed by Healthcare and Energy.

Against the trend, Contravisory Investment Management opened a new position in Oneok worth $6.62M.

  • Contravisory Investment Management's largest Q1 2022 buy was Oneok: 93,736 shares worth $6.62M.
  • Contravisory Investment Management added most to Elevance Health in Q1 2022, an estimated $5.9M increase.
  • Contravisory Investment Management's biggest Q1 2022 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $428K.
  • Contravisory Investment Management fully exited Garmin in Q1 2022, selling an estimated $8.98M.
  • Contravisory Investment Management's ten largest holdings make up 26% of its $352M portfolio in Q1 2022.
  • Contravisory Investment Management opened 108 new positions and closed 59 in Q1 2022.
  • Contravisory Investment Management's portfolio value fell 4.9% quarter-over-quarter to $352M.

Based on Contravisory Investment Management's 13F filing for Q1 2022, filed 8 Apr 2022.